齐普罗夫洛克萨和温带菌体之间的协同作用克服了由 lysogen 形成引起的治疗限制
P Lauman1,2, T R H Cassell1, J J Dennis3
1University of Alberta, Edmonton, Canada.
Scientific reports
|December 4, 2025
概括
温和菌体与抗生素相结合,显示出对抗药物耐药Burkholderia cepacia复合体 (Bcc) 细菌的承诺. 这种菌体-抗生素协同战略有效地克服了在Bcc感染中溶解原形成所带来的局限性.
科学领域:
- 微生物学 微生物学
- 细菌治疗疗法是一种细菌治疗.
- 抗微生物耐药性 抗微生物耐药性
背景情况:
- 菌体对于对抗耐药细菌至关重要.
- 形成 lysogens 的温带菌体的治疗潜力尚未得到充分探索.
- 温和的菌体-抗生素协同作用 (tPAS) 已被验证为大肠杆菌和P. aeruginosa.
研究的目的:
- 用温带菌体研究tPAS对Burkholderia cepacia复合体 (Bcc) 病原体的疗效.
- 确定tPAS是否可以克服Bcc物种中溶解原形成引起的抗菌限制.
- 探索溶解酶化频率与协同抗菌效应之间的关系.
主要方法:
- 使用温带菌体感染BCC物种,并与普洛克萨的亚抑制剂量结合使用.
- 评估了菌体-抗生素组合的抗菌活性和素形成.
- 量化 lysogenization 频率和 lysogen 耗尽率. 量化 lysogenization 频率和 lysogen 耗尽率.
主要成果:
- 温和的菌素-西普罗夫洛克萨辛组合显示出对Bcc物种的协同抗菌活性.
- 协同效应的大小与所使用的菌体的解质化频率相关.
- 在 lysogen 枯竭中观察到异质性,表明完全枯竭对于协同作用并不重要.
结论:
- 温和菌体可以有效地用作与抗生素对抗BCC病原体的协同辅助剂.
- tPAS显著扩大了对抗具有挑战性的Bcc感染的治疗选择.
- 这些发现支持将温带菌体更广泛地纳入治疗策略.
相关概念视频
01:16Viral Replication: Lysogenic Cycle
1.2K
The lysogenic cycle is a crucial viral replication strategy that allows bacteriophages to persist within host cells without immediately destroying them. This process is primarily observed in temperate phages, such as bacteriophage lambda (λ), which infects Escherichia coli. The cycle allows the viral genome to persist across bacterial generations while keeping host cells viable.Integration of the Viral GenomeUpon infection, bacteriophage lambda attaches to the bacterial surface and injects...
1.2K
01:30Lytic Cycle of Bacteriophages
77.3K
Bacteriophages, also known as phages, are specialized viruses that infect bacteria. A key characteristic of phages is their distinctive “head-tail” morphology. A phage begins the infection process (i.e., lytic cycle) by attaching to the outside of a bacterial cell. Attachment is accomplished via proteins in the phage tail that bind to specific receptor proteins on the outer surface of the bacterium. The tail injects the phage’s DNA genome into the bacterial cytoplasm. In the...
77.3K
00:43Lysogenic Cycle of Bacteriophages
67.3K
In contrast to the lytic cycle, phages infecting bacteria via the lysogenic cycle do not immediately kill their host cell. Instead, they combine their genome with the host genome, allowing the bacteria to replicate the phage DNA along with the bacterial genome. The incorporated copy of the phage genome is called the prophage. Some prophages can re-activate and enter the lytic cycle. This often occurs in response to a perturbation, such as DNA damage, but can also transpire in the absence of...
67.3K
01:26DNA Bacteriophages
758
Bacteriophages, or phages, are viruses that specifically infect bacteria, utilizing their genetic material to hijack host cellular machinery for replication. DNA bacteriophages employ single-stranded DNA (ssDNA) or double-stranded DNA (dsDNA) genomes. These phages exhibit diverse replication strategies and host interactions, influencing their ecological roles and applications in biotechnology and medicine.ssDNA BacteriophagesssDNA phages, with their small genomes, utilize unique strategies to...
758
01:20Viral Replication: Lytic Cycle
1.1K
Bacteriophages, or phages, are viruses that specifically infect bacteria. Among them, T-even bacteriophages, such as T4, exhibit a well-characterized lytic replication cycle in Escherichia coli (E. coli). This process ensures the rapid proliferation of the virus while ultimately leading to the destruction of the bacterial host.Attachment and DNA InjectionThe infection process begins with the recognition and binding of the T4 phage to the E. coli cell surface. Tail fibers of the phage...
1.1K
01:27Combined Effects of Drugs: Synergism
6.7K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Such synergistic combinations...
6.7K